Digestive diseases and sciences (Dig Dis Sci)

Journal PubWeight™ 9776.49‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. 1993 7.98
2 Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. 1995 6.36
3 GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. 1988 4.65
4 Factors predictive of adverse events following endoscopic papillary large balloon dilation: results from a multicenter series. 2012 4.35
5 Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease. 1984 3.76
6 Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. 1998 3.74
7 Nonalcoholic fatty liver disease: a review and update. 2010 3.72
8 Cytomegalovirus infection in patients with active inflammatory bowel disease. 2010 3.26
9 Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK. 1997 3.23
10 Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. 1993 3.18
11 Anismus in chronic constipation. 1985 3.16
12 Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of "abnormal" contractions. 1987 3.07
13 Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. 2005 2.87
14 Drug-induced autoimmune-like hepatitis. 2011 2.86
15 Tracheal aspiration of a capsule endoscope: a new case report and literature compilation of an increasingly reported complication. 2011 2.86
16 Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. 1998 2.84
17 Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. 1992 2.78
18 Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome. 2014 2.77
19 Effectiveness of concomitant enteral nutrition therapy and infliximab for maintenance treatment of Crohn's disease in adults. 2012 2.77
20 Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. 1995 2.75
21 Increased expression of 5-HT3 and NK 1 receptors in 5-fluorouracil-induced mucositis in mouse jejunum. 2013 2.70
22 Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. 1991 2.67
23 Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. 1991 2.63
24 Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. 1993 2.62
25 Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis. 2014 2.62
26 Ischemia-reperfusion injury of the intestine and protective strategies against injury. 2004 2.54
27 Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. 1980 2.53
28 A meta-analysis of the role of smoking in inflammatory bowel disease. 1989 2.53
29 HER-2/neu amplification is an independent prognostic factor in gastric cancer. 2006 2.53
30 Hypersensitivity to 5-ASA suppositories. 1997 2.51
31 Ascertainment of colonoscopy indication using administrative data. 2010 2.49
32 Postoperative ileus. 1990 2.48
33 Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. 1992 2.47
34 Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. 2002 2.46
35 Time trends of mortality from gastric cancer in Europe. 2011 2.44
36 Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer. 1982 2.43
37 Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. 2008 2.38
38 Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. 1981 2.36
39 Death due to acute pancreatitis. A retrospective analysis of 405 autopsy cases. 1985 2.33
40 The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers: a gastroscopic and photographic study. 1979 2.29
41 Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? 2007 2.28
42 One-day therapy for treatment of Helicobacter pylori infection. 1993 2.27
43 Saccharomyces boulardii in maintenance treatment of Crohn's disease. 2000 2.26
44 Splenic and portal venous obstruction in chronic pancreatitis. A prospective longitudinal study of a medical-surgical series of 266 patients. 1992 2.26
45 Adipose tissue: the new endocrine organ? A review article. 2008 2.26
46 Left-sided portal hypertension. 2007 2.24
47 Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. 1989 2.23
48 Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity. 2010 2.18
49 Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation. 2012 2.18
50 Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease. 1989 2.17
Next 50